Literature DB >> 33060833

Development and validation of a nomogram for the early prediction of preeclampsia in pregnant Chinese women.

Chao-Yan Yue1, Jiang-Ping Gao2, Chun-Yi Zhang1, Ying-Hua Ni1, Chun-Mei Ying3.   

Abstract

To make early predictions of preeclampsia before diagnosis, we developed and validated a new nomogram for the early prediction of preeclampsia in pregnant Chinese women. A stepwise regression model was used for feature selection. Multivariable logistic regression analysis was used to develop the prediction model. We incorporated BMI, blood pressure, uterine artery ultrasound parameters, and serological indicator risk factors, and this was presented with a nomogram. The performance of the nomogram was assessed with respect to its calibration, discrimination, and clinical usefulness. Internal validation was assessed. The signature, which consisted of 11 selected features, was associated with preeclampsia status (P < 0.1) for the development dataset. Predictors contained in the individualized prediction nomogram included BMI, blood pressure, uterine artery ultrasound parameters, and serological indicator levels. The model showed good discrimination, with an area under the ROC curve of 0.8563 (95% CI: 0.8364-0.8761) and good calibration. The nomogram still had good discrimination and good calibration when applied to the validation dataset (area under ROC curve of 0.8324, 95% CI: 0.7873-0.8775). Decision curve analysis demonstrated that the nomogram was clinically useful. The nomogram presented in this study incorporates BMI, blood pressure, uterine artery ultrasound parameters, and serological indicators and can be conveniently used to facilitate the individualized prediction of preeclampsia.

Entities:  

Keywords:  Inhibin-A; Nomogram; Prediction; Preeclampsia; Uterine artery Doppler

Mesh:

Year:  2020        PMID: 33060833     DOI: 10.1038/s41440-020-00558-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

1.  Doppler ultrasound of the maternal uterine arteries: disappearance of abnormal waveforms and relation to birthweight and pregnancy outcome.

Authors:  S Campbell; R S Black; C C Lees; V Armstrong; J L Peacock
Journal:  Acta Obstet Gynecol Scand       Date:  2000-08       Impact factor: 3.636

2.  One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation.

Authors:  G Albaiges; H Missfelder-Lobos; C Lees; M Parra; K H Nicolaides
Journal:  Obstet Gynecol       Date:  2000-10       Impact factor: 7.661

3.  Inhibin-A levels and severity of hypertensive disorders due to pregnancy.

Authors:  Gerda G Zeeman; James M Alexander; Donald D McIntire; William Byrd; Kenneth J Leveno
Journal:  Obstet Gynecol       Date:  2002-07       Impact factor: 7.661

4.  Uterine artery velocimetry in patients with gestational hypertension.

Authors:  T Frusca; M Soregaroli; C Platto; L Enterri; A Lojacono; A Valcamonico
Journal:  Obstet Gynecol       Date:  2003-07       Impact factor: 7.661

  4 in total
  3 in total

1.  Development and Validation of Multi-Stage Prediction Models for Pre-eclampsia: A Retrospective Cohort Study on Chinese Women.

Authors:  Zeyu Tang; Yuelong Ji; Shuang Zhou; Tao Su; Zhichao Yuan; Na Han; Jinzhu Jia; Haijun Wang
Journal:  Front Public Health       Date:  2022-05-30

2.  Development of a prediction model on preeclampsia using machine learning-based method: a retrospective cohort study in China.

Authors:  Mengyuan Liu; Xiaofeng Yang; Guolu Chen; Yuzhen Ding; Meiting Shi; Lu Sun; Zhengrui Huang; Jia Liu; Tong Liu; Ruiling Yan; Ruiman Li
Journal:  Front Physiol       Date:  2022-08-12       Impact factor: 4.755

3.  Development of a nomogram for predicting clinical outcome in patients with angiogram-negative subarachnoid hemorrhage.

Authors:  Anke Zhang; Zeyu Zhang; Wen-Bo Zhang; Xiaoyu Wang; Cameron Lenahan; Yuanjian Fang; Yujie Luo; Yibo Liu; Shuhao Mei; Sheng Chen; Jianmin Zhang
Journal:  CNS Neurosci Ther       Date:  2021-07-28       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.